$ALXN Recent News S&P 500 ekes out another record

New Post Public Reply Private Reply Replies (0) Message Board

Aug 18, 2014 at 11:06 AM

$ALXN Recent News

S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang
From every angle, technicals point to richer stocks 2:26 p.m. March 11, 2014 - The Trading Deck
U.S. stocks fall amid China worries 4:20 p.m. March 10, 2014 - Anora Mahmudova

Stock Market News for August 15, 2014 - Market News 10:10 a.m. Aug. 15, 2014 - Zacks.com
Alexion CEO Receives Nearly 17 Million for Sale of Company Stock 3:02 p.m. Aug. 14, 2014 - GuruFocus.com
Biggest Movers in Healthcare Stocks Now – ALXN ACT TEVA WST 2:00 p.m. Aug. 14, 2014 - InvestorPlace.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
Alnylam Pharmaceuticals Has Plenty On Its Plate 10:36 a.m. Aug. 9, 2014 - Seeking Alpha
Utilities Help Stocks Edge Up on Week 2:29 a.m. Aug. 9, 2014 - Barrons.com
GW Pharma, Insys Face Off In Cannabis Drug Space 3:45 p.m. Aug. 8, 2014 - Investors Business Daily
Today's Stocks Driving Success For The Health Care Sector 1:03 p.m. Aug. 8, 2014 - TheStreet.com
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales - Analyst Blog 11:00 a.m. Aug. 8, 2014 - Zacks.com
Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog 9:20 a.m. Aug. 8, 2014 - Zacks.com
Here's How Facebook, Alexion Teach Lessons In Tenacity 5:02 p.m. Aug. 7, 2014 - Investors Business Daily
NPS Pharma Reports Earnings in Q2 on Strong Gattex Sales - Analyst Blog 12:40 p.m. Aug. 7, 2014 - Zacks.com
Vertex's Price And Prospects Compared To Alexion 10:50 a.m. Aug. 7, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACAD CNC RMD LCI 2:00 p.m. Aug. 6, 2014 - InvestorPlace.com
Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog 2:00 p.m. Aug. 5, 2014 - Zacks.com
Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog 3:40 p.m. Aug. 4, 2014 - Zacks.com
3 Health Care Stocks Dragging The Sector Down 1:03 p.m. Aug. 4, 2014 - TheStreet.com
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog 11:10 a.m. Aug. 4, 2014 - Zacks.com
4 Biotech Stocks to Buy 6:35 a.m. Aug. 4, 2014 - InvestorPlace.com

Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
Financial Results, FDA Approvals, Orphan Drug Designations, and Certificates - Research Reports on Idenix, Baxter, Alexion, Alere and Zoetis 9:10 a.m. Aug. 7, 2014 - PR Newswire - PRF
European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:30 a.m. Aug. 1, 2014 - BusinessWire - BZX
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
European Medicines Agency Accepts Marketing Authorization Application for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:15 a.m. July 24, 2014 - BusinessWire - BZX
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors 8:02 a.m. July 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 10:00 a.m. July 10, 2014 - BusinessWire - BZX
Market Activity and Upcoming Quarterly Results - Analyst Notes on Bristol-Myers Squibb, Abbott, Alexion, Mallinckrodt and Baxter 6:10 a.m. July 8, 2014 - PR Newswire - PRF
Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate 4:02 p.m. July 7, 2014 - GlobeNewswire
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 5:55 a.m. July 7, 2014 - PR Newswire - PRF
Conference Call Schedules, Disclosures, Partnerships, and Acquisitions - Analyst Notes on Pfizer, Covidien, UnitedHealth Group, Alexion and Abbott 5:50 a.m. June 27, 2014 - PR Newswire - PRF
Alexion and Cincinnati Children’s Launch Rare Disease Innovation Fund 6:30 a.m. June 23, 2014 - BusinessWire - BZX
FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG) 6:39 a.m. June 17, 2014 - BusinessWire - BZX
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
Critical Alerts For Apple, Orexigen Therapeutics, NextEra Energy, Family Dollar Store, and Alexion Pharmaceuticals Technology Released By InvestorsObserver 9:31 a.m. June 10, 2014 - PR Newswire - PRF
Biotech Equities under the Scanner -- Research on Halozyme Therapeutics, Medivation, Achillion Pharma, and Alexion Pharma 8:10 a.m. June 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Circus Circus Vegas Offers Halloween Deals for Families

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...

SKE Invigorates IRONWORKS London's Music Vibe With E-Cigs

Bringing SKE's Flair to London's Music Scene Well, folks, hold onto your hats—SKE's thrown its weight behind IRONWORKS London, extending its reach deeper into the UK's electronic music scene. This ain't just another gig; we're talking about the second time SKE is flexing its sponsorship muscles in the UK music arena, officially angling for the vape category spotlight....

Are Shareholder Interests at Risk in These Deals?

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Anthropic's IPO Preparations Stir Investor Curiosity

Anthropic's Entrance: A New Horizon in AI Investment Gritty times afoot in the tech trenches, and Anthropic's prepping for an IPO ain't just a blip on the radar—it's a sledgehammer moment for folks keeping their eye on AI. Leverage Shares, through their Themes branch, are sniffing out opportunities to create new investment products. They're tiptoeing around launching...

Skechers Faces Shareholder Lawsuit: Must Act by Dec 21

Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...

The Sift: Slickdeals’ Game-Changing Black Friday Tool

Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...

Beta Bionics Faces Class Action Deadline Amid Controversy

Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...

PG&E Breaks Ground with Global Emergency Accreditation

Pioneering Emergency Management Standards The landscape of emergency management just got a shakeup, folks. PG&E, an energy utility giant that powers the lives of over 16 million Californians, bagged a distinction that doesn’t roll around every day—indeed, the first of its caliber in the utility sector. Earning accreditation from the big dogs at the Emergency...

Alfa Laval Secures EUR 1B Credit Facility Extension

Alfa Laval Banks on a New Financial Horizon Forget your morning rituals, Alfa Laval just pulled off a maneuver that's got industry tongues wagging. Thanks to a new EUR 1 billion revolving credit facility, they've bolstered their financial defenses, setting a robust foundation for the future. The facility, no dink-and-dunk affair, carries an initial five-year maturity. And...

TDS and Array Set for Q3 Results Amid Market Curiosity

The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...